Gil Blum
Stock Analyst at Needham
(4.16)
# 457
Out of 5,131 analysts
412
Total ratings
37.9%
Success rate
21.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $80 → $82 | $53.07 | +54.51% | 28 | Feb 13, 2026 | |
| SLDB Solid Biosciences | Reiterates: Buy | $16 | $6.19 | +158.48% | 3 | Feb 9, 2026 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $68.50 | +53.28% | 25 | Feb 5, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $15.60 | +66.67% | 29 | Jan 29, 2026 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $5 → $3 | $0.37 | +706.67% | 21 | Jan 13, 2026 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $1.40 | +614.29% | 34 | Jan 12, 2026 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $42 | $6.52 | +544.17% | 16 | Jan 9, 2026 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.55 | +174.51% | 7 | Dec 12, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $9 → $6 | $0.93 | +543.78% | 8 | Nov 4, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $104.51 | -33.02% | 21 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.55 | +119.78% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $4.00 | +350.00% | 7 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.49 | +129.23% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.97 | +407.61% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $17.79 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.27 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.28 | +119.95% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.86 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $13.10 | +266.41% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.65 | +263.64% | 23 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.31 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.25 | - | 9 | Oct 27, 2025 |
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Buy
Price Target: $80 → $82
Current: $53.07
Upside: +54.51%
Solid Biosciences
Feb 9, 2026
Reiterates: Buy
Price Target: $16
Current: $6.19
Upside: +158.48%
Arcellx
Feb 5, 2026
Reiterates: Buy
Price Target: $105
Current: $68.50
Upside: +53.28%
Nurix Therapeutics
Jan 29, 2026
Reiterates: Buy
Price Target: $26
Current: $15.60
Upside: +66.67%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5 → $3
Current: $0.37
Upside: +706.67%
Autolus Therapeutics
Jan 12, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $1.40
Upside: +614.29%
Cartesian Therapeutics
Jan 9, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $6.52
Upside: +544.17%
Absci
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $2.55
Upside: +174.51%
TScan Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $0.93
Upside: +543.78%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $104.51
Upside: -33.02%
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.55
Upside: +119.78%
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.00
Upside: +350.00%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $3.49
Upside: +129.23%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.97
Upside: +407.61%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $17.79
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.27
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.28
Upside: +119.95%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.86
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $13.10
Upside: +266.41%
Jul 26, 2024
Reiterates: Buy
Price Target: $6
Current: $1.65
Upside: +263.64%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.31
Upside: -
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.25
Upside: -